Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorg Dietrich

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
The Lancet. Haematology|January 29, 2021
The best matrix for the brain: advances in secondary CNS lymphomaJorg Dietrich
Neuro-Oncology Practice|April 4, 2022
Antiepileptic drug therapy in brain tumor patients: a complex relationshipJorg Dietrich
Continuum (Minneapolis, Minn.)|December 4, 2020
Neurotoxicity of Cancer TherapiesJorg Dietrich
Neurology|July 9, 2016
Author ResponseJorg Dietrich, Morgan Prust
Expert Opinion on Investigational Drugs|September 18, 2020
Ipilimumab: an investigational immunotherapy for glioblastomaGilbert Youssef, Jorg Dietrich
Cancer|January 23, 2019
Assessment and management of cognitive changes in patients with cancerMichael W Parsons, Jorg Dietrich
Continuum (Minneapolis, Minn.)|December 5, 2017
Neuroradiologic Pearls for Neuro-oncologyJoshua P Klein, Jorg Dietrich
Expert Opinion on Investigational Drugs|October 5, 2023
Investigational treatment strategies in glioblastoma: progress made and barriers to successThomas A Nelson, Jorg Dietrich
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2026
Neurological complications of current and emerging CAR-T cell therapiesAnna G Hauswirth, Jorg Dietrich
Neuro-Oncology Practice|May 31, 2021
Evaluation and management of chimeric antigen receptor (CAR) T-cell-associated neurotoxicityLuis Nicolas Gonzalez Castro, Jorg Dietrich
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
The Lancet. Haematology|January 29, 2021
The best matrix for the brain: advances in secondary CNS lymphomaJorg Dietrich
Neuro-Oncology Practice|April 4, 2022
Antiepileptic drug therapy in brain tumor patients: a complex relationshipJorg Dietrich
Continuum (Minneapolis, Minn.)|December 4, 2020
Neurotoxicity of Cancer TherapiesJorg Dietrich
Neurology|July 9, 2016
Author ResponseJorg Dietrich, Morgan Prust
Expert Opinion on Investigational Drugs|September 18, 2020
Ipilimumab: an investigational immunotherapy for glioblastomaGilbert Youssef, Jorg Dietrich
Cancer|January 23, 2019
Assessment and management of cognitive changes in patients with cancerMichael W Parsons, Jorg Dietrich
Continuum (Minneapolis, Minn.)|December 5, 2017
Neuroradiologic Pearls for Neuro-oncologyJoshua P Klein, Jorg Dietrich
Expert Opinion on Investigational Drugs|October 5, 2023
Investigational treatment strategies in glioblastoma: progress made and barriers to successThomas A Nelson, Jorg Dietrich
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 30, 2026
Neurological complications of current and emerging CAR-T cell therapiesAnna G Hauswirth, Jorg Dietrich
Neuro-Oncology Practice|May 31, 2021
Evaluation and management of chimeric antigen receptor (CAR) T-cell-associated neurotoxicityLuis Nicolas Gonzalez Castro, Jorg Dietrich
Pageof 17